CEA is highly expressed in colorectal carcinoma (CRC), medullary thyroid carcinoma (MTC), and small cell lung cancer (SCLC), with the first two being the subject of many preclinical studies. The gene discussed is CEACAM5; the disease is medullary thyroid gland carcinoma.